Interpretation of Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines （RIGHT for CPM）
10.13422/j.cnki.syfjx.20241126
- VernacularTitle:中成药临床应用实践指南的报告规范（RIGHT for CPM）解读
- Author:
Liaoyao WANG
1
;
Hejing PAN
1
;
Le ZHANG
2
;
Wenya WANG
2
;
Xing LIAO
2
Author Information
1. School of Basic Medical Sciences， Zhejiang Chinese Medical University， Hangzhou 310053， China
2. Center for Evidence-based Medicine， Institute of Basic Research in Clinical Medicine， China Academy of Chinese Medical Sciences， Beijing 100700， China
- Publication Type:Journal Article
- Keywords:
Chinese patent medicine;
clinical practice guidelines;
reporting checklist;
Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines （RIGHT for CPM）;
interpretation
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2025;31(1):211-218
- CountryChina
- Language:Chinese
-
Abstract:
The clinical practice guidelines for Chinese patent medicines （CPM） provide reference for the selection of national drug catalogs， the formulation of prescription collections in medical institutions， and the clinical use of CPM， constituting an important part of traditional Chinese medicine （TCM） guidelines. As a crucial part of Chinese drug supply guarantee system， CPM plays an important role in the treatment， prevention， and healthcare of many disease categories， whereas the application of CPM has problems of misuse and even abuse. To standardize the application of CPM， a research team at Zhejiang Chinese Medical University developed the Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines （RIGHT for CPM） based on the RIGHT checklist framework. The RIGHT for CPM checklist gathers key information from published CPM guidelines， existing TCM reporting checklists， and the RIGHT checklist and its extensions to form an initial pool of reporting items. Seventeen experts from different disciplines were invited to conduct two rounds of Delphi surveys， and the final checklist was reviewed and approved for publication by 18 leading experts in TCM research and guideline reporting from China and abroad. The RIGHT for CPM checklist adds 16 sub-items and revises 2 sub-items on the basis of the RIGHT checklist， highlighting the characteristics of CPM guideline reporting. It considers CPM selection and inclusion criteria， policy access， indications and symptoms， drug combination instructions， drug use in special populations， precautions， and recommendations of Western medical physicians， among others. This can further improve the quality and transparency of CPM guideline reporting， promote standardized reporting of CPM guidelines， and facilitate the rational clinical use of CPM. This article interprets the development process of the RIGHT for CPM checklist and the items that highlight the characteristics of CPM guidelines， with a view to promoting the application of the RIGHT for CPM checklist.
